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RESEARCH ARTICLE Open Access
The extent, quality and impact of patient
and public involvement in primary care
research: a mixed methods study
Steven Blackburn1* , Sarah McLachlan2, Sue Jowett3, Philip Kinghorn3, Paramjit Gill4, Adele Higginbottom1,5,
Carol Rhodes1,5, Fiona Stevenson6 and Clare Jinks1
Plain English summary
In the UK, more patients go to primary care than other parts of the health service. Therefore it is important for
research into primary care to include the insights and views of people who receive these services. To explore the
extent, quality and impact of patient and public involvement (PPI) in primary care research, we examined
documents of 200 projects and surveyed 191 researchers.
We found that about half of studies included PPI to develop research ideas and during the study itself. Common activities
included designing study materials, advising on methods, and managing the research. Some studies did not undertake
the PPI activities initially planned and funded for. PPI varied by study design, health condition and study population. We
found pockets of good practice: having a PPI budget, supporting PPI contributors, and PPI informing recruitment issues.
However, good practice was lacking in other areas. Few projects offered PPI contributors training, used PPI to develop
information for participants about study progress and included PPI to advise on publishing findings.
Researchers reported beneficial impacts of PPI. Most impact was reported when the approach to PPI included more
indicators of good practice. The main cost of PPI for researchers was their time. Many reported difficulties providing
information about PPI.
In partnership with PPI contributors, we have used these findings to develop:
 a new Cost and Consequences Framework for PPI highlighting financial and non-financial costs, benefits and harms
of PPI
 Fifteen co-produced recommendations to improve the practice and delivery of PPI.
Abstract
Background: To improve the lives of patients in primary care requires the involvement of service users in primary care
research. We aimed to explore the extent, quality and impact of patient and public involvement (PPI) in primary care
research.
Methods: We extracted information about PPI from grant applications, reports and an electronic survey of researchers of
studies funded by the NIHR School for Primary Care Research (SPCR). We applied recognised quality indicators to assess
the quality of PPI and assessed its impact on research.
Results: We examined 200 grant applications and reports of 181 projects. PPI was evident in the development
of 47 (24%) grant applications. 113 (57%) grant applications included plans for PPI during the study, mostly in
study design, oversight, and dissemination. PPI during projects was reported for 83 (46%) projects, including
(Continued on next page)
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designing study materials and managing the research. We identified inconsistencies between planned and
reported PPI. PPI varied by study design, health condition and study population.
Of 46 (24%) of 191 questionnaires completed, 15 reported PPI activity. Several projects showed best practice
according to guidelines, in terms of having a PPI budget, supporting PPI contributors, and PPI informing
recruitment issues. However few projects offered PPI contributors training, used PPI to develop information for
participants about study progress, and had PPI in advising on dissemination.
Beneficial impacts of PPI in designing studies and writing participant information was frequently reported. Less impact
was reported on developing funding applications, managing or carrying out the research. The main cost of PPI for
researchers was their time. Many researchers found it difficult to provide information about PPI activities.
Our findings informed:
 a new Cost and Consequences Framework for PPI in primary care research highlighting financial and non-financial
costs, plus the benefits and harms of PPI
 Fifteen co-produced recommendations to improve PPI in research and within the SPCR.
Conclusions: The extent, quality and impact of PPI in primary care research is inconsistent across research design and
topics. Pockets of good practice were identified making a positive impact on research. The new Cost and
Consequences Framework may help others assess the impact of PPI.
Keywords: Patient and public involvement, Quality, Impact, Mixed methods, primary care research, Cost and
consequences framework
Background
Actively involving patients and the public in research is
seen as a marker of good research practice because it leads
to research that is relevant, better designed, with clearer
outcomes, and a faster uptake of new evidence [1]. Now a
requirement and priority of many research funding bodies,
patient and public involvement (PPI) is promoted at all
stages throughout the research cycle [2]. The recent Na-
tional Institute for Health Research (NIHR) Going the
Extra Mile report highlighted the need to improve the
quality and practice of PPI in health and social care re-
search [3]. In response to NIHR recommendations by the
NIHR, INVOLVE has published their Values and princi-
ple’s Framework for best practice in PPI [4].
PPI has been documented in a number of research
areas [5, 6]. Positive impacts are reported for all stages
of research, including enhancing its quality and appro-
priateness, an increased understanding and insight of re-
searchers into their research field, and the increased
sense of self-worth, confidence and skills gained by PPI
contributors1 as a result of their involvement [7, 8]. PPI
has also been associated with success in achieving par-
ticipant recruitment targets in studies, securing funding,
designing study protocols and choosing relevant out-
comes [9, 10]. Recent research has identified the charac-
teristics of effective PPI [11] and the mechanisms
required to sustain it [12].
In contrast, reported negative impacts are PPI contrib-
utors’ frustration with the lengthy process and lack of
feedback, the extra time needed to complete research,
time constraints of patients and researchers, and the in-
creased financial costs [10]. Moreover, PPI can be tokenis-
tic due to negative attitudes of researchers and the
requirements of research funders [10, 13]. Variation in the
context of, and approaches to, PPI, combined with lack of
validated tools to assess its quality, causes challenges to
identify best practice of PPI and its impact [10, 14].
Though PPI in research is a clear priority for the govern-
ment, the NIHR and other research organisations, there is
growing, though limited, evidence relating to the costs (fi-
nancial and non-financial) and consequences (benefits and
harms) of PPI in research. This seems to be driven by the
lack of and poor quality of reporting [7, 15, 16].
Our study is set in the context of primary care re-
search. That is, research conducted within health ser-
vices providing first-contact care for patients (e.g.
general practices, district nursing, and community-based
health services) [17]. 90% of all NHS interactions occur
in primary care [18], with the management of chronic
illnesses a key component. Therefore it is important for
research into primary care to be informed by the in-
sights and perspectives of patients who receive these
services.
However, little is known about the extent, quality and
impact of PPI across the whole range of primary care re-
search. To date, the small number of primary care stud-
ies reporting on PPI [19–21] are largely limited to a
description of the PPI activities which have taken place.
More recently, a case study of a primary care research
centre reported how dedicated infrastructure and
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resourcing for PPI, flexible working practices, leadership,
and secure funding has enabled the fostering of sus-
tained long term PPI across all of its research [12, 22].
The literature in this area is limited and the benefits
and costs of PPI for both researchers and the public is
unclear. Our study therefore set out to gain a broader
understanding of PPI in primary care research. Specific
research questions were:
1. What is the extent of PPI in primary care research?
2. What is the quality of PPI in primary care research?
3. What is the impact of involvement on PPI
contributors, researchers and research institutions
involved?
4. What are the costs associated with PPI in health
research?
The four research questions were addressed through
use of surveys, analysis of relevant research documents
and a workshop. Results from research questions three
and four were analysed and structured as a cost-
consequence framework, a largely qualitative way of
summarising key costs (financial costs as well as nega-
tive impacts on individuals or institutions) and key bene-
fits (financial savings and positive impacts). Cost-
consequence analysis is typically used by economists
when it is not feasible to conduct a standard economic
evaluation. In this case, cost-consequence analysis was
adopted due to a lack of available data and recording in-
formation about PPI to accurately quantify all monetary
costs and the lack of an appropriate single metric for
summarising non-monetary consequences.
Methods
The study used a mixed methods approach consisting of
1) analysis of documents relating to research projects
such as grant applications, annual reports, final reports;
2) a survey of researchers and PPI contributors; and 3) a
workshop with eleven PPI contributors and the research
team to discuss the findings and co-produce recommen-
dations. The analysis of project documents was used to
provide evidence of the scope of PPI in primary care re-
search. The surveys were used to provide evidence on
the quality, experiences, and impact of PPI. The findings
informed the recommendations workshop and develop-
ment of the cost-consequences framework.
Setting
This study focused on research projects funded by and
taking place within the NIHR School of Primary Care
Research (SPCR) since its inception in 2008 to 2014.
This included all projects funded on each of the SPCR’s
annual funding rounds (FR1 to FR8). The SPCR is a
partnership between the leading academic centres for
primary care research in England. Through dedicated
funding, its remit is to increase the evidence base for
primary care practice through high quality research and
strategic leadership.
Patient and public involvement in this study
The study embraced PPI throughout every stage of the
research cycle, from developing the initial idea, design-
ing the study and being lay co-applicants (AH, CR) on
the grant application, through to working with the re-
searchers to understand the findings and writing the rec-
ommendations. Full details of the involvement of the
PPI contributors of our study team are published else-
where [23]; however the contribution of our PPI contrib-
utors are embedded throughout this article.
Analysis of project documents
We requested all documentation relevant to all projects
from the SPCR. This included grant applications, along with
annual and final reports provided by grant holders to the
SPCR. We also collected other documents containing data
on PPI in projects from the SPCR and from researchers
who had included PPI within their projects (e.g. posters pre-
sented at the annual SPCR Showcase event and articles).
Data from the documents were recorded using a data
extraction form and compiled in an electronic spread
sheet. The type of data extracted from each document is
shown in Table 1. Two members of the research team
(SB, SM) completed the data extraction. To examine the
scope of PPI in primary care research, the data from the
project documents were summarised using descriptive
statistics. We examined the change in the extent of PPI
activities over time, using each annual funding round as
a proxy measure of time. Subgroup analyses were con-
ducted to examine the frequency and type of PPI activity
by study design, disease/condition (categorised using the
Health Research Classification System [24]), study popu-
lation, and the age profile of the study population. De-
scriptions and explanations relating to PPI were
Table 1 Types of data extracted from the project
documentation
• Study design
• Disease/condition studied
• Study population
• SPCR funding round
• Presence of a section dedicated to PPI within the document
• Presence of PPI in the development of the grant application (including
a description of the type and number of public members involved)
• Description of plans for PPI (including a description of the type and
number of public members involved)
• Details of PPI activities conducted
• Explanation for any lack of PPI
• References to a specific budget for PPI
• References to rewards and recognition for involvement.
• Level of consistency between planned and reported PPI activities was
noted (including explanations for any discrepancies).
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analysed qualitatively to provide further insight to the
activities reported.
Researcher and PPI contributor surveys
A cross-sectional survey design was employed using self-
completed questionnaires. The researcher and PPI con-
tributor questionnaires were developed through a review
of the literature and a search for existing questionnaire
items on the costs and consequences of PPI. The contri-
bution of our three PPI contributors to develop the
questionnaires ensured that items reflected the range of
costs and consequences experienced by PPI contributors.
The questionnaires included items aligning with Boote
et al.’s [25] quality indicators to enable the assessment of
PPI activity against best practice (Table 2). Also, the
questionnaire included items relating to the type of PPI
activities and the perceived impact of these activities on
the research study and the respondent. Most items
included a free text box to allow the respondent to ex-
plain their answer or give further insights. The re-
searcher and PPI contributor questionnaires are
provided in Supplementary Files 1 and 2, respectively.
All Principal Investigators (lead researchers) of pro-
jects funded by the SPCR received an electronic survey
via email for each project that they were leading or had
led. Project details were provided by the SPCR. As the
details of PPI contributors involved in SPCR projects
were not available, an item was included in the re-
searcher survey to determine Principal Investigators’
willingness to pass on a paper-based questionnaire to
the public members involved in their projects. Our
PPI contributors were consulted about this recruit-
ment strategy. They felt that, while possibly not ideal,
particularly as this relied on good record keeping of
public members’ involvement, this approach was prag-
matic and acceptable.
Table 2 The principles and indicators of successful consumer involvement in NHS research. Adapted from Boote et al. [25]
Principle Indicator(s)
1. The roles of consumers are agreed between the
researchers and consumers involved in the research
The roles of consumers in the research were documented
2. Researchers budget appropriately for the costs
of consumer involvement in research
Researchers applied for funding to involve consumers
in the research
Consumers were reimbursed for their travel costs
Consumers were reimbursed for their indirect costs
(e.g. carer costs)
3. Researchers respect the differing skills, knowledge
and experience of consumers
The contribution of consumers’ skills, knowledge and
experience were included in research reports and papers
4. Consumers are offered training and personal support,
to enable them to be involved in research
Consumers’ training needs related to their involvement
in the research were agreed between consumers and
researchers
Consumers had access to training to facilitate their
involvement in the research
Mentors were available to provide personal and technical
support to consumers
5. Researchers ensure that they have the necessary
skills to involve consumers in the research process
Researchers ensured that their own training needs were
met in relation to involving consumers in the research
6. Consumers are involved in decisions about how
participants are both recruited and kept informed
about the progress of the research
Consumers gave advice to researchers on how to recruit
participants to the research
Consumers gave advice to researchers on how to keep
participants informed about the progress of the research
7. Consumer involvement is described in research reports The involvement of consumers in the research reports
and publications was acknowledged
Details were given in the research reports and publications
of how consumers were involved in the research process
8. Research findings are available to consumers,
in formats and in language they can easily understand
Research findings were disseminated to consumers involved i
n the research in appropriate formats (e.g. large print,
translations, audio, Braille)
The distribution of the research findings to relevant consumer
groups was in appropriate formats and easily understandable
language
Consumers involved in the research gave their advice on the
choice of methods used to distribute the research findings
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Descriptive statistics were calculated for all quantita-
tive items in the survey: types of PPI activities, costs (fi-
nancial and non-financial), and impacts. To examine the
quality of PPI in primary care research, we compared
PPI activity reported by Principal Investigators with
Boote et al’s quality indicators of best practice [25]. The
analysis focused on how many projects met each quality
indicator. Two of Boote et al’s [25] quality indicators re-
lated to the description and acknowledgement of PPI
contributors’ involvement in publications. Therefore for
the projects which the Principal Investigator in the sur-
vey reported PPI activities, we searched for related publi-
cations via the PubMed online search engine, using the
Principal Investigator’s name and key words from project
title as a search strategy. Retrieved publications were
scrutinized for information relating to PPI.
To explore whether projects with higher quality PPI
(as defined by achieving a higher number of indicators
of good practice, using Boote et al’s Quality Indicators
[25]) was associated with a higher level of perceived im-
pact, a quality-impact index score was also calculated
for each project. A Pearson correlation coefficient was
calculated between the number of quality indicators met
(the quality score) and the number of PPI activities
where Principal Investigators reported a perceived posi-
tive impact (the impact score).
A cost and consequences framework of PPI in primary
care research
Two researchers (PK, SJ) independently categorised sur-
vey items relating to the time spent on involvement activ-
ities and associated costs, impacts and related free text
comments as either costs (financial and non-financial)
and consequences (benefits and harms). An overall frame-
work of all potential financial and non-financial costs and
consequences of PPI was therefore constructed.
Recommendations workshop
Following completion of the data analysis, public mem-
bers who had been previously involved with the project
(AH, CR) plus seven other members of a Research User
Group at Keele attended a workshop with the research
team to discuss key findings of the study. The aim was
to co-develop recommendations to improve PPI practice
within the SPCR.
Ethical approval
Ethical approval was obtained from Keele University’s
Research Ethics Committee (21st March 2014).
Results
Documentary analysis
A total of 200 full project proposals, 233 annual reports
and 39 final reports were provided by the SPCR for the
documentary analysis. The annual and final reports pro-
vided data on 180 projects; reports for the remaining 20
projects were unavailable from the SPCR. However, for
one project for which reports were not available to the
research team, data on PPI were extracted from a poster
presented at an SPCR Showcase Event. Therefore, the
PPI activities reported in 181 projects were included in
the analysis.
Researcher and PPI contributor survey
One hundred ninety-one questionnaires were emailed to
Principal Investigators, of which 46 were completed and
returned (response rate 24%). The Principal Investigators
who responded to the survey were unable to pass on a
survey to the PPI contributors involved in their projects,
so we did not collect any data from PPI contributors at
this stage. Of the 46 responses received from Principal
Investigators, 15 (33%) reported PPI activity, most com-
monly in designing methods (8 out of 15) and develop-
ing participant information (7 out of 15).
Scope of PPI in primary care research
PPI during the development of grant applications Of
the 200 funded projects for which full grant applications
were available, there was evidence of PPI in the develop-
ment of the application for 47 (24%) projects. Just over
half of the applications (113, 57%) provided evidence of
plans to conduct PPI during the study. Table 3 provides
a summary of these projects by research design and
health conditions under study.
PPI during the projects Of the 181 projects for which
annual and/or final project reports were available (plus
one project whose information on PPI was extracted
from a SPCR poster), 69 (38%) projects had been com-
pleted, 108 (60%) were uncompleted and this data was
missing for three projects.
For all 181 projects (completed and uncompleted), PPI
activities was reported for 84 projects (46%), not re-
ported in 74 projects (41%), and for 23 projects (13%)
there was insufficient data available to determine
whether PPI had taken place or not. Where PPI had not
been reported in the project, a rationale for the absence
of PPI was provided for 26 projects (14%).
In the case of the 108 uncompleted projects, PPI activ-
ities were planned for 36 projects (33% of uncompleted
projects), there were no plans for PPI in 42 projects
(39% of uncompleted projects), and there was insuffi-
cient information available to determine whether PPI
was planned for the remaining 30 projects (18% of un-
completed projects). Where there were no plans for PPI,
a rationale for this decision was provided for seven pro-
jects (7% of uncompleted projects).
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Table 3 PPI in SPCR projects, by study design, health condition, population and population age
Projects (Grant
applications)
Projects with evidence
of PPI in developing
the grant application
(N = 200)
Projects with evidence
of plans for PPI during
the study in the grant
application (N = 200)
Projects (Annual/
Final Reports)a
Projects with evidence
of PPI reported in annual
/final reports (N = 181)
n (%) n (%) (Relative %)b n (%) (Relative %)b n (%) n (%) (Relative %)c
All Projects 200 (100) 47 (23.5) 113 (56.5) 181 (181) 83 (46.1)
Study Design
Mixed methods 47 (23.5) 15 (7.5) (31.9) 30 (15.0) (63.8) 39 (21.5) 24 (13.3) (61.5)
Qualitative 36 (18.0) 9 (4.5) (25.0) 23 (11.5) (63.9) 30 (16.6) 17 (9.4) (56.7)
Longitudinal cohort 29 (14.5) 5 (2.5) (17.2) 18 (9.0) (62.1) 29 (16.0) 11 (6.1) (37.9)
Intervention trial 25 (12.5) 6 (3.0) (24.0) 15 (7.5) (60.0) 23 (12.7) 14 (7.7) (60.9)
Systematic reviews 17 (8.5) 2 (1.0) (11.8) 7 (3.5) (0.0) 17 (9.4) 2 (1.1) (11.8)
Retrospective cohort 13 (6.5) 2 (1.0) (15.4) 4 (2.0) (30.8) 13 (7.2) 3 (1.7) (23.1)
Secondary analysis 8 (4.0) 0 (0.0) (0.0) 4 (2.0) (50.0) 8 (4.4) 3 (1.7) (37.5)
Cross sectional 7 (3.5) 4 (2.0) (57.1) 3 (1.5) (42.9) 7 (3.9) 4 (2.2) (57.1)
Methodological 5 (2.5) 1 (0.5) (20.0) 4 (2.0) (80.0) 4 (2.2) 1 (0.6) (25.0)
Case control 4 (2.0) 0 (0.0) (0.0) 1 (0.5) (25.0) 3 (1.7) 0 0 (0.0)
Multi-stage studyd 4 (2.0) 2 (1.0) (50.0) 2 (1.0) (50.0) 2 (1.1) 2 (1.1) (100)
Individual participant meta
analysis
3 (1.5) 0 (0.0) (0.0) 1 (0.5) (33.3) 2 (1.1) 1 (0.6) (50.0)
Othere 2 (1.0) 1 (0.5) (50.0) 1 (0.5) (50.0) 4 (2.2) 2 (1.1) (50.0)
Health Condition Under Study
General Health 28 (14.0) 9 (4.5) (32.1) 14 (7.0) (50.0) 22 (12.2) 9 (0.0) (40.9)
Cardiovascular 27 (13.5) 4 (2.0) (14.8) 16 (8.0) (59.3) 28 (15.5) 10 (5.5) (35.7)
Mental Health 21 (10.5) 5 (2.5) (23.8) 12 (6.0) (57.1) 17 (9.4) 11 (6.1) (64.7)
Cancer 16 (8.0) 7 (3.5) (43.8) 8 (4.0) (50.0) 16 (8.8) 10 (5.5) (62.5)
Metabolic and Endocrine 14 (7.0) 1 (0.5) (7.1) 6 (3.0) (42.9) 16 (8.8) 9 (5.0) (56.3)
Musculoskeletal 14 (7.0) 3 (1.5) (21.4) 6 (3.0) (42.9) 13 (7.2) 6 (3.3) (46.2)
Respiratory 13 (6.5) 3 (1.5) (23.1) 6 (3.0) (46.2) 12 (6.6) 5 (2.8) (41.7)
Multimorbidity 7 (3.5) 0 (0.0) (0.0) 1 (0.5) (14.3) 8 (4.4) 3 (1.7) (37.5)
Stroke 7 (3.5) 1 (0.5) (14.3) 3 (1.5) (42.9) 5 (2.8) 2 (1.1) (40.0)
Infection 5 (2.5) 1 (0.5) (20.0) 3 (1.5) (60.0) 5 (2.8) 1 (5.0) (20.0)
Renal and Urogenital 5 (2.5) 2 (1.0) (40.0) 5 (2.5) (100) 5 (2.8) 3 (1.7) (60.0)
Reproductive Health and
Childbirth
5 (2.5) 2 (1.0) (40.0) 5 (2.5) (100) 5 (2.8) 4 (2.2) (80.0)
Neurological 3 (1.5) 0 (0.0) (0.0) 3 (1.5) (100) 1 (0.6) 1 (0.6) (100)
Cancer, Mental Health 1 (0.5) 1 (0.5) (100) 0 (0.0) (0.0) 1 (0.6) 1 (0.6) (100)
Inflammatory and Immune
System
1 (0.5) 0 (0.0) (0.0) 0 (0.0) (0.0) 0 (0.0) 0 (0.0)
Oral and Gastrointestinal 1 (0.5) 0 (0.0) (0.0) 0 (0.0) (0.0) 1 (0.6) 0 (0.0) (0.0)
Skin 1 (0.5) 1 (0.5) (100) 1 (0.5) (100) 1 (0.6) 1 (0.6) (100)
Otherf 31 (15.5) 7 (3.5) (22.6) 24 (12.0) (77.4) 23 (12.7) 8 (4.4) (34.8)
Study population
Patients 134 (67.0) 26 (13.0) (19.4) 68 (34.0) (50.7) 123 (68.0) 54 (29.8) (43.9)
Patients & HCPs 37 (18.5) 11 (5.5) (29.7) 24 (12.0) (64.9) 31 (17.1) 20 (11.0) (64.5)
Healthcare professionals (HCPs) 15 (7.5) 5 (2.5) (33.3) 10 (5.0) (66.7) 8 (4.4) 3 (1.7) (37.5)
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Rationales provided for 26 projects (completed and
uncompleted) which did not report on PPI were similar,
referring mostly to the applicability and relevance of PPI
for the project. They included “user involvement was in-
tegrated into the original main trial, in which this project
is nested. No additional user involvement was needed
for the purposes of this project”; “this has been a data-
base study and as a result there has been no direct in-
volvement of patients or the public in this work”; “being
a straightforward questionnaire study, PPI input to the
project has been minimal”; or simply “not applicable”.
Change in the scope of PPI over time There was no
clear trend for an increase in PPI in the development of
grant applications or the reporting of PPI in annual/final
reports over time, using the SPCR funding rounds as a
proxy measure of time. However, there was a trend for
an increase over time in the percentage of project pro-
posals which provided details of plans for PPI for the de-
livery of the research (R2 = 0.62) (Fig. 1).
Budgeting for PPI Of the 113 grant applications that
included plans for PPI during the study, 57 (50%) made
reference to a budget for this and 32 (28%) referred to
rewards and/or recognition for those who would be in-
volved. There were no references to a budget for PPI in
any of the annual/final reports or posters obtained from
the SPCR, and only one reference to rewards and
Table 3 PPI in SPCR projects, by study design, health condition, population and population age (Continued)
Projects (Grant
applications)
Projects with evidence
of PPI in developing
the grant application
(N = 200)
Projects with evidence
of plans for PPI during
the study in the grant
application (N = 200)
Projects (Annual/
Final Reports)a
Projects with evidence
of PPI reported in annual
/final reports (N = 181)
n (%) n (%) (Relative %)b n (%) (Relative %)b n (%) n (%) (Relative %)c
General public 13 (6.5) 5 (2.5) (38.5) 10 (5.0) (76.9) 15 (8.3) 7 (3.9) (46.7)
Carers 1 (0.5) 0 (0.0) (0.0) 1 (0.5) (100) 1 (0.6) 0 (0.0) (0.0)
Study population age
Unspecified 93 (46.5) 19 (9.5) (20.4) 54 (27.0) (58.1) 83 (45.9) 35 (19.9) (43.4)
Adult (18+ years) 89 (44.5) 24 (12.0) (27.0) 50 (25.0) (56.2) 83 (45.9) 42 (23.2) (50.6)
Adult and Children 11 (5.5) 4 (2.0) (36.4) 7 (3.5) (63.6) 9 (5.0) 5 (2.8) (55.6)
Children and young adults
(0–17 years)g
7 (3.5) 0 (0.0) (0.0) 2 (1.0) (28.6) 6 (3.3) 1 (0.6) (16.7)
aIncluded one project whose data on PPI was obtained from an SPCR poster
bPercentage relative to the number of projects in each category in grant applications
cPercentage relative to the number of projects in each category in annual/final reports
dMulti-stage studies included case control and intervention trial (1), cross sectional and longitudinal cohort (1), systematic review and longitudinal cohort (1),
systematic review and secondary analysis
eIncluded projects to set up and maintain a SPCR PPI group (1) and a preliminary descriptive study (1)
fConditions not classified under the Health Research Classification System [24]
gIt was not always possible to determine the ages or age range of children from the study documentation. Sometimes, ages were provided, sometimes the
documentation referred to ‘children’. So we have assumed children and young adults to be 17 and under
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recognition for those involved. However, the research
team did not have access to the full costings for each
project and it is therefore possible that this represents
an underestimation of the number of projects for which
PPI was budgeted.
The scope of PPI by study design The extent of PPI
varied across study design. Across both grant applica-
tions and project reports, PPI was relatively more com-
mon for mixed methods, qualitative and interventional
trial designs study designs compared to other study
types (Table 3). Relatively, PPI was most prevalent in the
development of grant applications for projects with a
cross sectional design (4 of 7 projects, 57%). Evidence of
PPI was relatively least frequent in cohort (longitudinal
and retrospective), methodological (study of research
methods or development of data collection systems),
systematic reviews and analysis of secondary data study
designs.
When examining individual types of project docu-
ments, the data suggest a certain degree of inconsistency
between planned and reported PPI. Plans for PPI within
grant applications were relatively frequent for methodo-
logical and longitudinal cohort designs compared to
other study types. However, reported PPI within annual/
final reports was more common for cross sectional de-
signs but less common for methodological design (as
well as retrospective cohort and systematic reviews).
The scope of PPI by health condition In terms of
health condition researched, PPI in the development of
grant applications and reported involvement during the
study was relatively more common for projects focusing
on cancer, renal and urogenital, reproductive health and
childbirth (Table 3). PPI was most frequently planned
for studies in the fields of neurology and other types of
health conditions not listed in the Health Research Clas-
sification System [24] (labelled ‘Other’ in Table 3). How-
ever, evidence of PPI was relatively least frequent for
studies on cardiovascular, metabolic and endocrine,
stroke, infection and multimorbid (multiple, co-existing)
health conditions.
The scope of PPI by study population and age
Though the study population of two-thirds of SPCR
funded projects was patients only, projects focused on
the general public, health care professionals only, and
both patients and health care professionals, tended to
have more PPI described in grant applications (both to
develop the application and plans during the projects)
(Table 3). Except for the carers category, reported PPI
during the study ranged from 38% (3 out of 15 projects
on healthcare staff ) to 65% of projects (20 out of 37 pro-
jects on patients and health care professionals) within
each population category. PPI was not reported in the
annual and/or final reports of the single project involv-
ing carers.
Inconsistencies were noted again between planned and
reported PPI during the study across population categories.
For example, for general public or health care professional
study populations, the relative proportion of projects
reporting PPI activities during the study in their annual/
final reports was 30% lower than the proportion of projects
with plans for PPI described in the grant applications.
Projects focused on children tended to have less PPI
described in proposals and annual/final reports com-
pared to projects focusing on other age groups. For all
other age groups PPI was similar: 20–36% in the devel-
opment of grant applications; 56–64% in plans for PPI;
43–56% reported PPI during the study. However, for
nearly half of all projects (93, 47%), the age group of the
study population was unspecified or difficult to ascertain
from the project documents.
The type of PPI Of the 200 grant applications, PPI ac-
tivities reported during the development of projects re-
lated to consulting with patients and members of the
public and gaining their comments and feedback on
plans for research (24 projects, 12%) and contributing to
the grant application (20 projects, 10%). Advising on
study methods, such as outcomes and recruitment
methods, were specifically reported in 14 grant applica-
tions (7%). A range of planned PPI activities were out-
lined in the grant applications and reported in annual/
final reports, relating to different stages of the research
cycle (Fig. 2). Plans within grant applications for involve-
ment in managing research through membership of a
project steering committee or management group were
most common (51 projects, 26%), followed by involve-
ment in dissemination of project findings (41 projects,
21%). Designing study methods, analysing/interpreting
data and designing study materials (such as question-
naires) were also frequently planned involvement activ-
ities. Planned PPI in conducting the research and
recruiting participants were the lowest areas of activity.
However, the proportions of the PPI activities reported
during the study were considerably lower than the
planned activities described in grant applications. The
most frequent activities reported during the project were
designing study materials (33 projects, 18%), designing
methods (25 projects, 14%) and managing the research
(17 projects, 9%). To explore this inconsistency further,
reports of PPI activities in project annual and/or final re-
ports (either already conducted or plans to conduct for
uncompleted projects) were compared with plans (and
non-plans) for PPI outlined in their associated grant ap-
plications. This was done for 179 projects where both
the grant application and annual and/or final reports
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were available (Fig. 3). Over a third of these 179 projects
(65, 36%) reported the PPI activities as proposed in the
grant applications, including 27 projects (15%) which
had no plans to do PPI anyway.
However there was inconsistency for 70 projects (39%):
20 projects (11%) reported more PPI than originally
planned; 50 projects (28%) reported less than originally
planned (including 23 projects (13%) which did not do any
of the PPI planned). Information on the discrepancies be-
tween planned and reported PPI activities was not available
in the project documentation. In most cases where more
PPI was reported that originally planned, the annual and/or
final reports documented PPI activities that was not part of
a project’s grant application. It is speculated that any add-
itional PPI was conducted as the project evolved and new
opportunities for involvement were created. For 64 projects
(35%), the annual and/or final reports made either no refer-
ence to the PPI activities planned in the grant application,
or made references to a few PPI activities only, but not all
that were planned. It is possible that for some of the un-
completed projects, plans for future PPI activities outlined
in the grant application but not yet done were not reported.
For six projects (3%), however, it was explained in the re-
ports that ‘[the] PPI member no longer want[ed] to be in-
volved in the study’; there was less PPI than planned
because ‘it was a highly technical study and utilised an-
onymous clinical data with no direct patient contact’; there
has been “no real PPI in the project…and the PPI section is
not applicable since the project involved a secondary ana-
lysis of a database with specific policy relevant questions”;
and “not applicable” or “none” was provided in the PPI sec-
tion of the final report (3 projects, 2%).
There was insufficient information to make a judge-
ment on the consistency of planned versus reported PPI
for 44 other projects (25%). In most of these, the nature
of the PPI could not be determined due to the insuffi-
cient information about PPI provided in either the grant
application or the annual and/or final reports.
Quality of PPI in primary care research
The quality of PPI was assessed using the data from the
15 Principal Investigators who responded to our survey
Unclear
44 projects, 25%
Consistent:
65 projects, 36%
20 projects,
11%
50 projects,
28%
Inconsistent:
70 projects, 39%
More than proposed
Less than proposed
Fig. 3 Consistency of PPI activities reported in annual/final reports compared to the plans for PPI within the project proposal (N = 179)
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Fig. 2 The nature of PPI planned in SPCR project proposals and reported in annual/final reports
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and reported PPI in their project. Overall, there was
variation in how best practice, according to the quality
indicators reported by Boote et al. [25], was met across
studies (Fig. 4). Best practice was more frequently
achieved in terms of offering PPI contributors personal
and technical support (13 out of 15 projects, 87%); in-
volving PPI contributors in advising on recruitment is-
sues (11 out of 15 projects, 73%) and having a specific
budget for PPI (9 out of 15 projects, 60%). Fewer studies
met best practice for PPI in terms of PPI contributors
advising on informing participants about study progress
(1 out of 15 projects, 7%); advising on dissemination
methods (1 out of 15 projects, 7%) or having to access
to training (3 out of 15 projects, 20%). We could not
provide evidence towards the endorsement of the quality
indicators: ‘PPI training needs are agreed’ (this was to be
captured via the patient survey) and ‘Distribution of re-
search findings to relevant patient groups was in appro-
priate formats and easily understandable language’.
The impact of PPI from the researcher’s perspective
Principal Investigators most commonly reported impact
for study processes with the most PPI activity (i.e. design-
ing methods and developing participant information). Per-
ceived impact of PPI on the research process and
individual Principal Investigators was largely positive and
included benefits such as improving the clarity of informa-
tion, increased recruitment and follow-up rates, validation
of findings and more useful outputs for clinicians and
patients. The only negative impact reported was the view
that a more homogenous study sample may have been re-
cruited, since the young PPI contributors encouraged their
friends to participate in a study on reproductive health in
young people. Despite reported PPI activity in developing
the grant application (3 out of 15, 20%), managing the re-
search (3 out of 15, 20%), and conducting the research (2
out of 15, 13%), Principal Investigators reported minimal
perceived impact in these areas.
No Principal Investigators reported a negative impact
of PPI on them personally but most (10 out of 15, 67%)
believed that it had little impact on the reputation of
their institution. However, most researchers (13 out of
15, 87%) reported that they would engage with PPI in
their research again, regardless of whether or not it was
a requirement set down by funders. From the free text
responses in the questionnaire, some researchers
expressed a positive impact of PPI:
“Very helpful in helping me gain a better understanding
of the issues involved with [disease]” (PI119)
“Feedback from patient representatives raised some key
concerns which were important to address in our branding
and overall presentation from the outset” (PI116)
“[PPI] provide a reality check on patient benefit of
research, broaden perspectives and focus on the lived
experience” (PI89)
0 1 2 3 4 5 6 7 8 9 1011 12131415
Public involvement adviced on informing participants about
study progress
Public involvement advised on dissemination methods
Contribution of PPI included in research reports and papers *
Public involvement members had access to training
Roles of public involvement members are documented
Public involvement members are reimbursed for expenses^
Researchers training needs for public involvement are met
Pubic involvement costs included in grant application
Appropriate feedback given to public involvement members
Public involvement advised on recruitment issues
Public involvement members offered personal and practical
support#
Number of SPCR projects
Fig. 4 Levels of best practice for PPI in SPCR projects, according to Boote et al’s quality indicators [25]. ^ Combination of two quality indicators
linked with expenses: travel costs and indirect costs (e.g. carer costs); * Combines three quality indicators: ‘contribution of PPI included in research
reports and papers’, ‘PPI acknowledged in research reports and papers’ and ‘details of PPI reported in research reports and publications’. Data
obtained from a PubMed search for articles associated with the 15 projects included in the analysis; # Adaptation of the quality indicator: ‘PPI
offered mentors for personal and technical support’; $ Adaptation of the quality indicator: ‘Research findings were distributed to patients involved
in the research in an appropriate format’
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A few principal investigators offered some alternative ex-
periences and less positive viewpoints of PPI in research:
“Sometimes patients are really helpful and give good
ideas and have good contacts. I am sorry to be cynical
but it is also a requirement for funders so you HAVE
to do it” (PI70)
“Young people can be unreliable – it’s sometimes
difficult to know whether they will turn up or not, and
to plan accordingly.” (PI90)
While the respondent in the above quote has commen-
ted on young people, it should be noted, however, that
this is not generalizable of all young PPI contributors.
The participation of all PPI contributors can be im-
pacted by many factors, such as availability on scheduled
meeting dates, changes in health status and other
commitments.
Quality-impact index scores Figure 5 shows the
Quality-Impact Index scores based on the Principle In-
vestigators’ responses relating to the quality and impact
of PPI activities for the 15 projects included in the re-
search survey. There was a moderate positive correlation
between the Quality Score (number of quality indicators
met by a project) and Impact Score (number of PPI activ-
ities in which the PI reported a perceived impact) (Pearson
correlation coefficient, r = .50, p = .056). Though statisti-
cally insignificant, this results suggests a greater perceived
impact of PPI activity for projects where a higher number
of quality indicators for PPI were met.
The financial costs of PPI
The most significant cost from a researcher perspective
appeared to be the researcher’s time. However,
researchers reported a variable numbers of hours related
to PPI, ranging from 0 to 30 h as a total across all
activities.
Half of Principal Investigators (8 out of 15, 53%) re-
ported that they ‘Always’ or ‘Sometimes’ offered some
form of payment to PPI contributors and a third (5 out
of 15, 30%) reimbursed expenses. Principal Investigators
reported that public members received payment for at-
tending meetings (6 out of 15, 40%), reviewing docu-
ments in their own time (2 out of 15, 13%) and
attending events (1 out of 15, 7%). Payment for other ac-
tivities (e.g. conducting the research, responding to let-
ters and emails from researchers) was not reported.
Travel costs (e.g. car mileage, public transport, parking)
and food and drink were the only expenses reimbursed.
However, few studies were able to confirm the actual
financial costs associated with PPI. A third of the re-
spondents reported difficulty in providing general infor-
mation about PPI in their project(s) (5 out of 15, 30%)
and almost half (7 out of 15, 47%) found it difficult to
give information relating to the costs of PPI. Free text
responses indicated that the researchers did not keep re-
cords of the costs associated with PPI activity in their
projects. Due to the overall lack of systematic recording
of resourcing PPI activity and the time lag for some of
the older projects in the sample, the responses of the
Principal Investigators on the costs and time commit-
ment of PPI are likely to be underestimated.
A new cost and consequences framework of PPI in research
Table 4 presents a framework of the individual costs and
consequences for both the research/researcher and pa-
tient. Responses from the researcher survey provided in-
formation for the costs and consequences framework
under sub-headings of researcher, research project, re-
search institution and funder. As no responses were
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Fig. 5 Quality-Impact Index scores: The association between the Quality Score (number of quality indicators met by a project) and the Impact
Score (number of PPI activities which the PI reported a perceived impact)
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Table 4 Costs and Consequences Framework
Impact upon Costs (−) Benefits (+)
Researcher - Time (recruiting PPI contributors; travelling to
meet with PPI contributors; meetings; electronic
communication; preparing newsletters)
- Increased pressure/stress
- Sensitivity to criticism
+ A motivating factor, with PPI contributors
bringing an enthusiasm to the project, a
keenness to see results
+ PPI contributors supportive of the project
+ Researchers gaining a better understanding
of the condition of interest
Research
Project
Shaping the research question
and maintaining focus
+ Setting and maintaining focus on the
research question
+ Addressing important issues but also
ensuring a degree of realism
Research methods/design - Can result in duplication of effort
(PPI involvement and qualitative work)
+ Helping to make surveys and processes
relevant, accessible and acceptable
+ Ensuring research is beneficial to patient
group
Recruitment & recruitment
materials
- Potentially homogenous sample + Relevance, clarity & accessibility of
recruitment materials
+ Making useful contacts, increasing
recruitment rates
Conducting & managing research - PPI contributors can be unreliable (this
was reported in the case of young people)
- Direct payment of PPI contributors for
attending meetings
- Travel costs (either the researcher visiting
the PPI representative or the PPI representative
attending meetingsa)
- Food and refreshment costs
- External venues
+ Validity and safety of research
+ Improved follow-up rates
Commenting on results + Opportunities to gain feedback and to
validate the results.
+ PPI contributors helping to interpret the
data.
Dissemination - Financial cost of PPI contributors attending
conferences and external events
+ Promotion of outputs when these take
the form of training modules or tool kits
+ Guidance in terms of presenting results
in a format useful to non-researchers.
Generating new research questions
(expanding upon current research)
+ Generating new/future research questions
Research Institution - Diversion of research funds to PPI (opportunity
cost in terms of funded researcher time, etc.)
- IT and other support infrastructures/resources
(including printing & internal room bookings)
+ Increased impact of research
+ Recognition as a centre with expertise
and experience of involving patients and
public in research (raising the institution’s
profile)
Funder + Avoiding devoting resources to a topic
which is not important (e.g. exploring an
intervention which is not appealing to
service users)
PPI contributors - Opportunity cost (paid work, child care, informal
care & leisure time)
- Monetary costs not reimbursed (travel, formal
child care)
- Negative impact on health associated with stress,
anxiety or frustration
- Complications in terms of state provided
welfare payments
+ Increased understanding & knowledge
of one’s own condition
+ Increased awareness of treatment options
and how to access services
+ Developing or enhancing skills (e.g. public
speaking, team work, IT) – possibly through
formal training
+ Understanding of research and research
processes
+ Positive emotional impact associated with
meeting new people, feeling as though one is
doing something worthwhile and generally
being active
Entries in italics were identified from the literature but not verified by respondents
a Sometimes included within the direct payment
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received for the patient survey, costs and consequences
identified from the literature are included in the
framework.
Recommendations workshop
Following the data analysis by the research team, public
members who had been previously involved with the
project plus other members of a Research User Group at
Keele attended a workshop. The aim was to co-produce
recommendations to improve PPI practice within the
SPCR. Three PPI contributors of the study, eight other
members of the Research User Group at Keele and the
research team came together to discuss as a group the
key findings of the study and consider recommendations
to address the findings, build upon existing good prac-
tice and improve PPI in research. During the workshop
consensus was achieved on the general content of the
recommendations. Following the workshop, the research
team mapped the recommendations to those in the
NIHR ‘Going the Extra Mile’ report [3], INVOLVE’s
‘Values and Principles Framework’ [4] and the SPCR
strategy for PPI [26]. To ensure consistency with these
national priorities and directions, the research team re-
fined the final wording of our recommendations, which
were reviewed and agreed upon by our PPI contributors
(Table 5).
Discussion
This is the first study to systematically investigate the
quality and impact of PPI across a wide cohort of pri-
mary care research studies. Furthermore, we have ap-
plied recognised quality indicators to assess the quality
of PPI and linked the level of quality with its perceived
impact on the research process. We have also identified
and developed a framework of the costs (financial and
non-financial) and consequences of PPI in primary care
research. This should enable others to assess the impact
of different approaches to PPI on key research outcomes
and the people involved.
Previous studies have tended to focus on scope and im-
pact, i.e. what PPI has taken place and how this may or
may not have made a difference to the research process.
However, knowing the quality of PPI (or how well it has
been undertaken) is just as essential. New Standards for
Table 5 Recommendations for improving the practice and delivery of PPI in research
Key Findings Recommendations for improving PPI in research
Best Practice
A. Overall PPI in research was low and inconsistent across
research design and topics
1. Promote PPI as a core research function in all research by raising awareness
of its value and impact
B. PPI was mostly limited to a few activities in the research cycle 2. Identify and share good examples of PPI activity across the research
cycle to improve range and quality of PPI in future funded projects
3. Raise awareness of and promoting the role of PPI in the lowest areas
of activity, where appropriate and justified
C. ‘Best Practice’ was inconsistent 4. Create dedicated champion(s) for PPI within research institutions to promote
best practice
5. Establish and implement a best practice framework to enable appropriate
and meaningful PPI
6. Stimulate sharing of best practice and resources for PPI across research
organisations and institutions
7. Improve the skills of researchers and member of the public for PPI
8. Establish a culture in which a) rewards and reimbursement of expenses are
offered to PPI contributors as a matter of routine practice and b) PPI is
appropriately costed in research
9. Improve and support the recording and reporting of PPI
10. Improve the accountability of public funded research to the general public
D. Time to do PPI is the biggest consequence to researchers 11. Raise awareness of time commitment for meaningful PPI so researchers can
plan for it effectively
E. PPI is good for research and researchers 12. Continue to showcase and celebrate the impact of PPI in research
SPCR Systems and Processes
A. Overall PPI activity in research was low 13. Increase the overall PPI activity in SPCR projects, by developing networks
for PPI groups and researchers, and encouraging sustainable processes and
infrastructure for PPI
B. PPI was mostly limited to a few activities in the research cycle 14. Increase the range of appropriate PPI in SPCR funded research, by providing
more guidance and support to researchers and grant reviewers
C. PPI is poorly recorded and reported 15. Improve the recording and reporting of PPI in SPCR to promote
transparency, support diversity and enable the evaluation of impact
by improving reporting form templates and better monitoring of PPI
in SPCR activities and funded research
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Public Involvement are expected in 2018 [27]. INVOLVE
have published resources on good practice and ap-
proaches to PPI, including a Values and Principles
Framework [4]. There are a few appraisal guidelines and
frameworks for assessing the quality of PPI [25, 28], in-
cluding a recently published framework designed to help
researchers to recognise the ethical issues when involv-
ing the public during the design of research studies [29].
In particular, Boote et al. [25] produced eight principles
of successful PPI in NHS research, with each principle
having at least one clear and valid indicator (or measure)
of good practice (Table 2). Furthermore, the GRIPP2
(Guidance for Reporting Involvement of Patients and
Public) checklist has been developed to enhance the
quality of PPI reporting [16]. Nevertheless, we are not
aware of any studies that have formally evaluated the
quality of PPI in research.
Our study has shown that PPI has not been routinely
undertaken across SPCR-funded research studies. While
some have included PPI at different stages of research,
most projects have not in either developing the grant ap-
plication, and/or whilst conducting the research, or both.
This does not seem to have improved over time, despite
becoming a requirement of funding. PPI was reported
most frequently in the management of studies (e.g. steer-
ing group membership), and designing study materials
(e.g. questionnaires) and methods (e.g. recruitment strat-
egy, intervention design), but less frequently for other
aspects of the research process (e.g. developing and
reviewing participant information leaflets, commenting
on the study protocol, conducting the research, develop-
ing future research areas). Similar studies on the extent
and type of PPI have reported similar findings [5, 6].
Furthermore, the extent of PPI in primary care research
was inconsistent across research design, with PPI seem-
ingly less prevalent in study designs where there was less
direct contact with patient/participants during the study.
The wide variability of PPI across health research topics
identified in this study is difficult to interpret or provide
reasons for but our findings suggest that the level of PPI
in the research of some health conditions is markedly
lower. These findings indicate that greater awareness of
the value of PPI throughout the research cycle, across
research designs and in different health conditions is
required.
The quality of PPI reported by Principal Investigators
did not always meet guidelines for best practice. Though
there were a few projects which conducted good quality
PPI, findings from our researcher survey highlighted par-
ticular areas where best practice was not being followed.
For example, in a number of projects PPI contributors
were not offered payment for their time or reimburse-
ment of expenses; and few projects documented the role
of PPI contributors or engaged with them regarding the
dissemination of research findings. We assessed quality
in terms of meeting indicators of good practice. While,
we were not able to identify specific examples of poor
practice in either the analysis of project documents or
the researcher survey, we did find that researchers spent
variable amounts of time on PPI activities during a study
(ranging 0 to 30 h). This suggests that those who spent
fewer or minimal hours on PPI may not have taken suffi-
cient time to have meaningfully engaged with the public.
Furthermore, whilst we acknowledge that not all of
Boote et al.’s quality indicators may be relevant for all
study types (e.g. obtaining advice from PPI contributors
on recruitment issues may not be relevant for studies
where there is no participant recruitment, such as sys-
tematic reviews or some cohort studies) they provide a
benchmark of quality that ought to be achieved if a
study involved members of the public. This study was
conducted before INVOLVE’s Values and Principles
Framework was published [4]. However, most of Boote
et al. quality indicators are incorporated in some form
or another within this new framework and the soon to
be launched Standards for Public Involvement [27] . Yet
it is too early at this stage to tell how INVOLVE’s Values
and Principles Framework will be used in practice and/
or how well the National Standards for Public Involve-
ment might be used to assess and improve the quality of
PPI. Nevertheless, future studies should consider how
the National Standards for Public Involvement, GRIPP2
reporting checklist and other PPI resources and tools
complement each other, in the context of the costs and
consequences of PPI highlighted in this study. This
should help drive forward improvements in this field in
a coherent and consistent way. For example the financial
and non-financial costs of PPI highlighted in this study
should be considered when using INVOLVE’s Budgeting
for Involvement Cost Calculator.
Our survey highlighted that researchers found it diffi-
cult to provide information on PPI and its costs. We
have also shown that it is difficult to contact public
members who have been involved in research, as re-
searchers were unable to pass the PPI contributor survey
to those involved in their research. Reasons for are not
entirely clear and we are not aware of similar findings in
the literature. Some researchers reported that they did
not have this information. So it is possible that the re-
searchers and/or their organisations did not systematic-
ally and routinely keep records of PPI activity (or at least
were not able to readily access these records at the time
of completing the survey). This could be due, in part, to
a possible lack of administrative support in some
organisations.
A key finding of this study was the inconsistency be-
tween the plans to conduct PPI during a study and the
reported delivery of that activity. The fact that PPI
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activities were often different to those described in re-
search proposals - and sometimes planned PPI was not
conducted at all - is problematic. Mathie et al. also re-
ported a lack of documentation providing evidence of
monitoring or how the PPI strategy within a study may
have changed as the research develops [5]. This suggests
a need for research funders to keep a check on PPI ac-
tivity within research projects and to help researchers to
make realistic plans for PPI at the outset.
This study complements the results of similar studies:
 Mixed methods design and interventional trials
tended to have the most PPI compared to other
research designs [5, 6]. PPI was less common in
observational and cohort studies [5].
 The most commonly stated PPI activity was
membership of steering committees and reviewing
patient information leaflets [5, 6]
 Increased time in building relationship with PPI
contributors and planning and managing PPI is a
major consideration for researchers [6, 10–12]
 There is limited amount of available information about
PPI in publicly accessible research documents [5]
The limitations to this study include:
1. A low response rate to the researcher survey (24%).
While this is in line with similar studies [5], the
length of questionnaire and the approximate 45 min
completion time may have been a barrier to
participation. Nevertheless, the level of detail was
necessary to obtain a comprehensive understanding
of PPI in primary care research. Secondly, some
researchers commented that it was difficult to recall
details of the PPI in studies that may have begun as
early as 2008.
2. Although it is not unreasonable to suggest that the
direct costs of PPI (e.g. payment to individuals,
reimbursement of expenses, room hire, etc.) could
and should be recorded, it is likely that financial
systems differ across universities, and there may
also be problems, particularly in terms of workload,
obtaining access to that level of detail once a
project has been completed.
3. Data from the documentary analysis was
inconsistent due to changes in the SPCR application
and reporting forms over the funding rounds.
Nevertheless, many of the annual/final reports
contained very little information, and were
incomplete or ambiguous. This highlights a problem
with recording and reporting of PPI activity. This
made extracting data difficult and the research team
sometimes made a judgement by consensus as to
the meaning of the information.
4. We were not able to conduct the PPI contributor
survey as we experienced difficulties with accessing
PPI contributors to invite them to participate. As
the contact details of PPI contributors involved
with SPCR work were not available, we decided to
ask Principal Investigators to pass the survey to PPI
contributors who had been involved in their
projects. Unfortunately, all Principal Investigators
who responded to the survey were unable (due to
lack of recorded contact information) to pass on
the postal survey to PPI contributors. This meant
that we were unable to gather data on the costs and
consequences of involvement from PPI
contributors. However, members of the Research
User Group at Keele were involved in the analysis
of the data and the development of
recommendations to ensure some representation of
the patient and public perspective.
5. We originally planned to observe PPI in research
studies. In the final section of the survey, Principal
Investigators were asked to indicate whether they
had any forthcoming meetings with PPI planned,
and if so whether they were happy for two
researchers to observe the meeting. Unfortunately,
most respondents did not have any meetings with
PPI planned, and one respondent was not willing
for us to observe their meeting.
Role of PPI in the study
Public members have played a fundamental role in shap-
ing the project, from the initial development of the re-
search idea to the dissemination and implementation of
findings. The role of PPI has been described and embed-
ded through this article. In addition to the activity
already described, there has also been involvement in
the dissemination of early project findings with a PPI
contributor co-presenting with a researcher at the IN-
VOLVE Conference 2014. Two lay co-applicants were
invited to comment on and contribute to the plain Eng-
lish summary of this article and the final project report
to the SPCR. They also commented on their experience
of the research study and their views of its findings
(Table 6).
While this study was funded by the SPCR, we did not
include it as part of the analysis of documentation and
surveys in order to remain independent. However, we
worked with our PPI contributors (AH, CR) to conduct
our own self-assessment of the quality of PPI in this
study against Boote et al.’s quality indicators [25] as a
separate exercise (Additional file 1). We achieved 10 out
of the 11 quality indicators. This suggests the PPI in this
study was of high quality. The single indicator not
achieved was PPI in advising on informing participants
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about study progress. This might have been achieved if
the survey of PPI contributors had been completed.
Furthermore, to highlight the benefits and challenges
of PPI experienced, we produced our own Cost and
Consequences Framework for this study (see Add-
itional file 2). This provides an example of the use of the
Cost and Consequences Framework in practice. We have
included relevant items about the PPI activity that we
experienced during the course of this study. We have
not included items relating to ‘researchers gaining a bet-
ter understanding of the condition of interest’ as this
was not a study of a particular health condition. The ex-
ercise has identified areas that we need to be aware of
and improve on in future studies involving PPI contribu-
tors (e.g. ensuring all PPI activities are fully costed and
budgeted), and many benefits of PPI that need to be re-
ported and shared (e.g. PPI as a motivating factor, with
PPI contributors bringing an enthusiasm to the project,
and a keenness to see results).
Future impact of this study
The results of this study have provided a detailed ac-
count of PPI within primary care research and have
shown the variability of PPI in projects to date. In par-
ticular, findings have highlighted areas for improvement
in PPI. This has led to the development of recommenda-
tions for good PPI practice, in collaboration with mem-
bers of a Research User Group, to ensure that the
patient perspective is represented. Implementation of
these recommendations, which complement the NIHR
‘Going the Extra Mile’ report [3], INVOLVE’s ‘Values
and Principles Framework’ [4], Standards for Public In-
volvement [27] and the NIHR School for Primary Care
Research (SPCR) PPI Strategy [26], will ensure that PPI
activities meet quality indicators and that standardised
records of PPI activities are kept to facilitate the evalu-
ation of impact. The new Costs and Consequences
Framework considers many potential benefits, harms
and costs (financial and non-financial) of PPI which will
help others assess the wider impacts of PPI. Further, the
surveys developed within the project can be used by the
SPCR and others to collect detailed data on the costs
and consequences of PPI in future projects and also alter
grant application forms and project reports to improve
reporting of PPI activities.
Conclusion
PPI in primary care research is inconsistent in terms of
its extent, nature and quality across research design and
topics. There is scope for improvement in terms of:
1) establishing the costs and consequences for
researchers and PPI contributors of involvement in
research
2) recording and reporting the contribution and
impact of PPI
3) promoting and implementing best practice, and PPI.
This study did identify pockets of good practice and
this tended to be reported as making a positive im-
pact on researchers and research studies. We were
unable to access PPI contributors to obtain their
views and experiences. Nevertheless, the public per-
spective, through PPI involvement in our study, was
instrumental in interpreting the findings and co-
producing recommendations to improve PPI in pri-
mary care research. The findings of this study have
informed a cost and consequences framework which
may help others assess the impact of PPI.
Endnotes
1We have used the term ‘PPI contributors’ to collect-
ively describe members of the public actively involved in
research projects, including patients, members of the
public, service users and carers.
Table 6 Experience of lay co-applicants and co-authors (CR, AH)
regarding their involvement in this study and its findings
CR: “As a lay coordinator of a growing group of research users involved
in a variety of primary care research projects across a clinical trials unit, I
was very aware of the varied approaches to PPI being undertaken both
regionally and nationally. So I was very interested in being involved in a
project looking at PPI within a group of projects across one funder,
looking particularly at the costs and benefits of PPI to the patients and
the researchers, as not all costs are quantifiable and those that are, are
not routinely recorded. Yet in my experience many patients and
researchers go above and beyond what is asked of them, because they
sincerely believe that patient involvement is an absolute must for good
rigorous primary care research that can go on to be implemented to
improve patients’ daily care. I was also keen to be involved in looking at the
results and how they could be used to inform PPI practice for the future.
However, it was disappointing that no opportunities for observations of
meetings were forthcoming and quite worrying that no details of
patients involved in the studies were available, so no real patient
perspective could be obtained of what the costs and benefits to the
patients were throughout the studies. So this highlights for me a gap in
the literature where more research needs to be undertaken to fully
understand the costs and benefits for the patients involved in primary
care research.
However I was impressed with the further specific recommendations on
systems and processes compiled to fully integrate PPI into any future
SPCR projects, which showed a real commitment from the SPCR to
learn from the study findings.”
AH: “I have enjoyed being a co-applicant on this study. I feel that I have
been involved in all areas of the study. I think that the study is essential
as it shows the inconsistency of reporting PPI.
I feel very disappointed about the response rate for the questionnaire,
as no patient data was collected due to researchers being unwilling or
unable to do this. This proves that there is a large gap here that needs
to be addressed. I have also been surprised that in a lot of cases there
were no plans for PPI, and for many researchers they held insufficient if
any information. On the positive side - this paper will highlight areas for
improvement and hopefully that will help to change attitudes and
perspectives in the future.”
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